Seek Labs Launches Open Impact Program at Clinton Global Initiative to Advance Therapeutic Development for Neglected Infectious Diseases

New Commitment to Action will apply Seek Labs’ BioSeeker AI and Sequence Ablation Therapeutics platform to diseases historically underserved by traditional therapeutic development SALT LAKE CITY, Sept. 22, 2026 (GLOBE NEWSWIRE) — Seek Labs, a TechBio company building programmable platforms to decode, program, and resolve diseases, today announced the Open Impact Sequence Ablation Therapeutics Program, […]